PAYER READY CREDENTIALING & COMPLIANCE
ICD-10-CM 2026 · Effective October 1, 2025

ICD-10 D75.838

Billable / Specific

Other thrombocytosis

D75
Block
2
Synonyms
168
LCDs
18
Payer Policies
6
Linked CPTs

About ICD-10-CM D75.838

ICD-10-CM code D75.838 represents Other thrombocytosis. This is a billable/specific code in the Blood and Blood-forming Organs chapter (block D75). The 2026 edition of ICD-10-CM D75.838 became effective on October 1, 2025.

Inclusion Terms / Approximate Synonyms

Clinical terms and conditions classified under D75.838. Per CMS ICD-10-CM Tabular 2026.

  • Reactive thrombocytosis
  • Secondary thrombocytosis

Coding Notes

Code Also

  • underlying condition, if known and applicable

Medicare LCD Coverage for D75.838

Local Coverage Determinations (LCDs) from CMS MACs that list D75.838 as a covered diagnosis.

168 LCDs

Showing top 10 of 168 total . Click a CPT for full coverage scope.

CMS LCD: Billing and Coding: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
Article ID: 59938, Effective: , 13 covered, 0 non-covered
CPT 81479 →
CMS LCD: Billing and Coding: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
Article ID: 59938, Effective: , 13 covered, 0 non-covered
CPT 0027U →
CMS LCD: Billing and Coding: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
Article ID: 59938, Effective: , 13 covered, 0 non-covered
CPT 81219 →
CMS LCD: Billing and Coding: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
Article ID: 59938, Effective: , 13 covered, 0 non-covered
CPT 81339 →
CMS LCD: Billing and Coding: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
Article ID: 59938, Effective: , 13 covered, 0 non-covered
CPT 81207 →
CMS LCD: Billing and Coding: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
Article ID: 59938, Effective: , 13 covered, 0 non-covered
CPT 81206 →
CMS LCD: Billing and Coding: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
Article ID: 59938, Effective: , 13 covered, 0 non-covered
CPT 81279 →
CMS LCD: Billing and Coding: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
Article ID: 59938, Effective: , 13 covered, 0 non-covered
CPT 0040U →
CMS LCD: Billing and Coding: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
Article ID: 59938, Effective: , 13 covered, 0 non-covered
CPT 81208 →
CMS LCD: Billing and Coding: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
Article ID: 59938, Effective: , 13 covered, 0 non-covered
CPT 81338 →

Commercial Payer Coverage

Coverage policies from major commercial payers referencing D75.838.

18 policies

5 Medicare

Billing and Coding: Lab: Flow Cytometry
Policy ID: ART-55717
Billing and Coding: Flow Cytometry
Policy ID: ART-56464
Billing and Coding: Genomic Sequence Analysis Panels in the Treatment of Hematolymphoid Diseases
Policy ID: ART-56793
Billing and Coding: Erythropoiesis Stimulating Agents (ESAs)
Policy ID: ART-56795
Billing and Coding: Lab: Flow Cytometry
Policy ID: ART-57689

CPT Codes Commonly Billed with D75.838

Procedures frequently paired with this diagnosis based on PayerReady's Dx↔Px linkage data.

6 linkages
  • 0027U CMS LCD: Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms CMS LCD
  • 81270 CMS LCD: Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms CMS LCD
  • 81338 CMS LCD: Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms CMS LCD
  • 81339 CMS LCD: Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms CMS LCD
  • 81219 CMS LCD: Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms CMS LCD
  • 81279 CMS LCD: Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms CMS LCD

ICD-10 D75.838, Billing FAQ

Is ICD-10 code D75.838 billable? +

Yes, D75.838 is a billable ICD-10-CM code that can appear as a primary or secondary diagnosis on claims.

What other names or terms map to D75.838? +

ICD-10 D75.838 includes: Reactive thrombocytosis; Secondary thrombocytosis.

What CPT codes are commonly billed with D75.838? +

Procedures frequently paired with D75.838 include: 0027U, 81270, 81338, 81339, 81219.

Get the full PayerReady toolkit

Free access to CPT/ICD-10 lookup, denial appeals, fee comparator, and claim auditing with credentialing enrollment.

Start free →

Run this code through our claim audit tool

Check NCCI bundling, MUE limits, and modifier logic before submission.

Try the auditor →

Did this page help?

Quick signal so we know what to improve.

Thanks!

If you want a code reference page that doesn't exist yet, email coding@payerready.com.

Sorry to hear that.

Tell us what's missing or wrong: coding@payerready.com. We respond within 5 business days.

Reviewed by the PayerReady Medical Coding Team

Verified against the CMS 2026 code set on July 16, 2026.

Powered by 11K CPT · 98K ICD-10 · 860K MPFS rates · 4.5M NCCI edits · 9.5M NPIs. Our data methodology · About our coding team

Every month un-credentialed is revenue you never bill

Sign up free, add your first provider, and watch the pipeline start moving this week.

Ask CredBrain

Answers from your credentialing team's verified knowledge base

Hi, I'm CredBrain. I answer from your credentialing team's verified knowledge base: payer join paths, state rules, timelines, associate billing, and enrollment workflows. If I don't have a verified answer, I'll say so and point you to your team. What would you like to know?

Try asking